Tetrylammonium

Tetrylammonium

SCHEMBL3279281

CC[N+](CC)(CC)CC.O=C([O-])[O-].[H+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.53
▸ NFKB1 P19838 3/20 0.53
▸ KCNA1 Q09470 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ FFAR3 O14843 3/20 0.38
▸ HDAC3 O15379 2/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ HDAC2 Q92769 2/20 0.38
▸ HDAC8 Q9BY41 2/20 0.38
▸ BBOX1 O75936 3/20 0.37
▸ CA1 P00915 3/20 0.35
▸ CES2 O00748 2/20 0.35
▸ CES1 P23141 2/20 0.35
▸ CYP3A4 P08684 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrylammonium SCHEMBL168440 0.97 TSHR (0.57) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL18144308 0.93 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL8030879 0.90 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL9146986 0.90 TSHR (0.50) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL30349943 0.87 CA1 (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL49874 0.87 CA1 (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL168442 0.87 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL36800 0.87 TSHR (0.53) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL8538098 0.85 CA4 (0.56) TSHRNFKB1KCNA1KDM4EPMP22
Tetrylammonium SCHEMBL3361488 0.84 CA1 (0.50) TSHRNFKB1KCNA1KDM4EPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210140096-A1 GRAPHENE MATERIAL COATING AND PREPARATION METHOD THEREOF, AIR FILTRATION DEVICE AND SYSTEM HUBEI HIGHLAND GRAPHENE TECHNOLOGY CO., LTD. (CN) 2021-05-13 — — US claimed
US-5693599-A Flux washing agent MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1997-12-02 — — US claimed
EP-4039760-B1 POLISHING COMPOSITION FUJIMI INC (JP) 2026-04-08 — — EP disclosed
EP-4717720-A1 CATALYST COMPOSITION, BLOCKED POLYISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION, COATING FILM, AND METHOD FOR FORMING COATING FILM Tosoh Corporation (JP) 2026-04-01 — — EP disclosed
US-20250232831-A1 METHOD FOR PREDICTING CELL MEMBRANE PERMEABILITY OF CYCLIC PEPTIDE FUJIFILM CORPORATION (JP) 2025-07-17 — — US disclosed
EP-4578866-A1 METHOD FOR PREDICTING CELL MEMBRANE PERMEABILITY OF CYCLIC PEPTIDE FUJIFILM Corporation (JP) 2025-07-02 — — EP disclosed
WO-2024262553-A1 CATALYST COMPOSITION, BLOCKED POLYISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION, COATING FILM, AND METHOD FOR FORMING COATING FILM 東ソー株式会社 2024-12-26 — — WO disclosed
WO-2024202500-A1 BLOCKED POLYISOCYANATE COMPOSITION, CURING AGENT FOR AQUEOUS COATING, AQUEOUS COATING COMPOSITION, AND COATING FILM 東ソー株式会社 2024-10-03 — — WO disclosed
WO-2024043251-A1 METHOD FOR PREDICTING CELL MEMBRANE PERMEABILITY OF CYCLIC PEPTIDE 富士フイルム株式会社 2024-02-29 — — WO disclosed
EP-4039760-A1 POLISHING COMPOSITION Fujimi Incorporated (JP) 2022-08-10 — — EP disclosed
CN-114450376-A Polishing composition 福吉米株式会社 2022-05-06 — — CN disclosed
EP-2105798-A1 DEVELOPING SOLUTION AND METHOD FOR PRODUCTION OF FINELY PATTERNED MATERIAL Sony Corporation (JP) 2009-09-30 — — EP disclosed
EP-1334084-A4 PHOSGENE-FREE PROCESS FOR PREPARING CARBAMATES PHARMACIA & UPJOHN CO LLC (US) 2005-11-02 — — EP disclosed
EP-1334084-A2 PHOSGENE-FREE PROCESS FOR PREPARING CARBAMATES PHARMACIA & UPJOHN COMPANY (US) 2003-08-13 — — EP disclosed
US-6528678-B2 Reacting an amine, such as 1-phenylpiperazine, with an alkylating agent, such as benzyl chloride, in the presence of carbon dioxide and cesium carbonate. PHARMACIA& UPJOHN COMPANY 2003-03-04 — — US disclosed
US-20020120140-A1 Phosgene-free process for preparing carbamates PHARMACIA & UPJOHN COMPANY 2002-08-29 — — US disclosed
WO-2002034698-A2 PHOSGENE-FREE PROCESS FOR PREPARING CARBAMATES PHARMACIA & UPJOHN COMPANY (US) 2002-05-02 — — WO disclosed
US-5693599-A Flux washing agent MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1997-12-02 — — US disclosed
US-5516928-A REACTION OF ISOPHORONE AND HYDROGEN CYANIDE USING QUATERNARY AMMONIUM CATALYST BASF AKTIENGESELLSCHAFT (DE) 1996-05-14 — — US disclosed
EP-0269949-A2 Process for producing a high purity quaternary ammonium hydroxide MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1988-06-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020120140-A1 Phosgene-free process for preparing carbamates CPS1, MGMT, ALPG TSHR 3219/4885NFKB1 4000/4885KCNA1 3276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback